{"id":"clm_616A4BA20B30","entity":"abbott-laboratories","predicate":"research_and_development","value":"2,741,000,000 United States dollar","value_json":{"fy":2023,"accn":"0001628280-24-005348","form":"10-K","filed":"2024-02-16","concept":"us-gaap:ResearchAndDevelopmentExpense"},"valid_from":"2023-12-31","valid_to":"2024-12-31","published":"2024-02-16","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Abbott Laboratories research and development: 2,741,000,000 United States dollar\", as of 2023-12-31 (until 2024-12-31). Claim clm_616A4BA20B30, https://asof.is/claim/clm_616A4BA20B30, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm.","url":"https://asof.is/claim/clm_616A4BA20B30","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AD76C5C835C9","supersedes":["clm_2B9EF111FA51"],"first_seen_at":"2026-11-08T16:56:09.404533+00:00","updated_at":"2026-11-08T16:56:16.878388+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1800/000162828024005348/0001628280-24-005348-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2023","published_at":"2024-02-16T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2023, filed 2024-02-16"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}